| 26th Nov 2019 7:00 am |
RNS |
Voluntary Delisting from the Nasdaq Capital Market |
| 20th Nov 2019 5:51 pm |
RNS |
Holding(s) in Company |
| 18th Nov 2019 12:12 pm |
RNS |
Directorate Changes |
| 14th Nov 2019 6:13 pm |
RNS |
Result of General Meeting |
| 11th Nov 2019 7:00 am |
RNS |
Settlement Agreement |
| 28th Oct 2019 4:14 pm |
RNS |
Holding(s) in Company |
| 25th Oct 2019 3:51 pm |
RNS |
Holding(s) in Company |
| 25th Oct 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 25th Oct 2019 12:02 pm |
RNS |
Price Monitoring Extension |
| 25th Oct 2019 7:00 am |
RNS |
Posting of Circular and Notice of General Meeting |
| 24th Oct 2019 7:00 am |
RNS |
U.S. Army-funded project to Evaluate Iclaprim |
| 21st Oct 2019 3:00 pm |
RNS |
Timing of General Meeting and Circular |
| 21st Oct 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 21st Oct 2019 12:02 pm |
RNS |
Price Monitoring Extension |
| 10th Oct 2019 7:00 am |
RNS |
Motif Bio confirms receipt of FDA meeting minutes |
| 3rd Oct 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 3rd Oct 2019 12:02 pm |
RNS |
Price Monitoring Extension |
| 3rd Oct 2019 7:00 am |
RNS |
Change of Adviser |
| 2nd Oct 2019 7:00 am |
RNS |
Conditional Placing |
| 30th Sep 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 30th Sep 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 30th Sep 2019 2:22 pm |
RNS |
Half-year Report |
| 17th Sep 2019 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 17th Sep 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 4th Sep 2019 2:57 pm |
RNS |
Holding(s) in Company |
| 2nd Sep 2019 7:00 am |
RNS |
Amended Loan and Security Agreement |
| 30th Aug 2019 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 30th Aug 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 19th Aug 2019 7:00 am |
RNS |
NIH to Evaluate Iclaprim Activity against Listeria |
| 1st Aug 2019 7:00 am |
RNS |
Amended Loan and Security Agreement |
| 26th Jul 2019 7:00 am |
RNS |
Receipt of Deficiency Notice from Nasdaq |
| 26th Jul 2019 7:00 am |
RNS |
Motif Bio Confirms Meeting Date with U.S. FDA |
| 19th Jul 2019 7:00 am |
RNS |
Motif Bio-Receipt of Deficiency Notice from Nasdaq |
| 18th Jul 2019 4:30 pm |
RNS |
Holding(s) in Company |
| 15th Jul 2019 7:00 am |
RNS |
US FDA meeting request and package submitted |
| 28th Jun 2019 5:13 pm |
RNS |
Holding(s) in Company |
| 28th Jun 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 28th Jun 2019 4:36 pm |
RNS |
Price Monitoring Extension |
| 26th Jun 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 26th Jun 2019 12:02 pm |
RNS |
Price Monitoring Extension |
